Kalimuthu Karuppanan

Title: Innovations of Kalimuthu Karuppanan in Inflammatory Disease Treatment.

Introduction

Kalimuthu Karuppanan is an accomplished inventor based in Davis, CA. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic proteins for treating inflammatory diseases. His work is characterized by a focus on innovative solutions that address pressing medical challenges.

Latest Patents

Kalimuthu holds a patent for "Fusion proteins for treating inflammatory diseases." This invention provides plant-made elafin-Fc fusion proteins specifically designed for treating inflammatory lung diseases. The fusion proteins include one or more point mutations that enhance their properties, such as increased resistance to oxidation and cleavage, as well as an extended half-life. Additionally, the patent encompasses polynucleotides encoding the fusion proteins, recombinant cells, expression vectors, and transgenic plants that contain the coding sequences for these fusion proteins. Methods for producing these fusion proteins are also detailed in the patent.

Career Highlights

Kalimuthu is affiliated with the University of California, where he continues to advance his research and innovation in the field of biotechnology. His work has garnered attention for its potential to improve treatment options for patients suffering from inflammatory diseases.

Collaborations

Kalimuthu collaborates with notable colleagues, including Karen A McDonald and Carroll E Cross. These partnerships enhance the research and development of his innovative solutions.

Conclusion

Kalimuthu Karuppanan's contributions to the field of biotechnology, particularly through his patent on fusion proteins, exemplify the impact of innovative research on medical treatments. His work continues to pave the way for advancements in the treatment of inflammatory diseases.